Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 93 of the 93 references it cites were found in a registry or an index.

Drug-encapsulated blend of PLGA-PEG microspheres: in vitro and in vivo study of the effects of localized/targeted drug delivery on the treatment of triple-negative breast cancer

Open access

Abstract

Triple-negative breast cancer (TNBC) is more aggressive and difficult to treat using conventional bulk chemotherapy that is often associated with increased toxicity and side effects. In this study, we encapsulated targeted drugs [A bacteria-synthesized anticancer drug (prodigiosin) and paclitaxel] using single solvent evaporation technique with a blend of FDA-approved poly lactic-co-glycolic acid-polyethylene glycol (PLGA_PEG) polymer microspheres. These drugs were functionalized with Luteinizing Hormone-Releasing hormone (LHRH) ligands whose receptors are shown to overexpressed on surfaces of TNBC. The physicochemical, structural, morphological and thermal properties of the drug-loaded microspheres were then characterized using Fourier Transform Infrared Spectroscopy (FTIR), Scanning Electron Microscopy (SEM), Dynamic Light Scattering (DLS), Nuclear Magnetic Resonance Spectroscopy (NMR), Thermogravimetric Analysis (TGA) and Differential Scanning Calorimetry (DSC). Results obtained from in vitro kinetics drug release at human body temperature (37 °C) and hyperthermic temperatures (41 and 44 °C) reveal a non-Fickian sustained drug release that is well-characterized by Korsmeyer-Peppas model with thermodynamically non-spontaneous release of drug. Clearly, the in vitro and in vivo drug release from conjugated drug-loaded microspheres (PLGA-PEG_PGS-LHRH, PLGA-PEG_PTX-LHRH) is shown to result in greater reductions of cell/tissue viability in the treatment of TNBC. The in vivo animal studies also showed that all the drug-loaded PLGA-PEG microspheres for the localized and targeted treatment of TNBC did not caused any noticeable toxicity and thus significantly extended the survival of the treated mice post tumor resection. The implications of this work are discussed for developing targeted drug systems to treat and prevent local recurred triple negative breast tumors after surgical resection.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-020-71129-0

Cites

93 of 93 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 SEM images of (A) PLGA-PEG_PGS, (B) PLGA-PEG_PGS-LHRH, (C) PLGA-PEG_PTX, (D) PLGA-PEG_PTX-LHRH, (E) PLGA-PEG microspheres. (F) Mean particle size distributions of drug-loaded and control PLGA-PEG microspheres.
Figure 1 SEM images of (A) PLGA-PEG_PGS, (B) PLGA-PEG_PGS-LHRH, (C) PLGA-PEG_PTX, (D) PLGA-PEG_PTX-LHRH, (E) PLGA-PEG microspheres. (F) Mean particle size distributions of drug-loaded and control PLGA-PEG microspheres.CC BY · PubMed Central
Figure 2 (a) FTIR spectra of the synthesized drug-loaded (PLGA-PEG_PGS, PLGA-PEG_PGS-LHRH, PLGA-PEG_PTX, PLGA-PEG_PTX-LHRH) microspheres and control (PLGA-PEG) microspheres. (b) A representative 1HNMR spectrum for drug-loaded PLGA-PEG microspheres.
Figure 2 (a) FTIR spectra of the synthesized drug-loaded (PLGA-PEG_PGS, PLGA-PEG_PGS-LHRH, PLGA-PEG_PTX, PLGA-PEG_PTX-LHRH) microspheres and control (PLGA-PEG) microspheres. (b) A representative 1HNMR spectrum for drug-loaded PLGA-PEG microspheres.CC BY · PubMed Central
Figure 3 (a) TGA curves of control PLGA-PEG microspheres and drug-loaded PLGA-PEG microspheres. (b) DSC thermographs of freeze-dried drug-loaded and control PLGA-PEG microspheres, respectively.
Figure 3 (a) TGA curves of control PLGA-PEG microspheres and drug-loaded PLGA-PEG microspheres. (b) DSC thermographs of freeze-dried drug-loaded and control PLGA-PEG microspheres, respectively.CC BY · PubMed Central
Figure 4 In vitro release profile of (a) PLGA-PEG-PGS microspheres, (b) PLGA-PEG-PTX, (c) PLGA-PEG-PGS-LHRH, (d) PLGA-PEG-PTX-LHRH drug-loaded microspheres at 37 °C, 41 °C and 44 °C, respectively. In all cases (n = 3, @p > 0.05 vs. control).
Figure 4 In vitro release profile of (a) PLGA-PEG-PGS microspheres, (b) PLGA-PEG-PTX, (c) PLGA-PEG-PGS-LHRH, (d) PLGA-PEG-PTX-LHRH drug-loaded microspheres at 37 °C, 41 °C and 44 °C, respectively. In all cases (n = 3, @p > 0.05 vs. control).CC BY · PubMed Central
Figure 5 A plot of Gibb’s free energy versus Temperature for various drug-loaded PLGA-PEG formulations.
Figure 5 A plot of Gibb’s free energy versus Temperature for various drug-loaded PLGA-PEG formulations.CC BY · PubMed Central
Figure 6 SEM images of surfaces of drug-loaded PLGA-PEG microspheres after 57 days exposure to phosphate buffer saline at pH 7.4: and cross-sections (note the different magnifications/scaling bars). The white arrows show evidence of the progression of material removal and degradation site.
Figure 6 SEM images of surfaces of drug-loaded PLGA-PEG microspheres after 57 days exposure to phosphate buffer saline at pH 7.4: and cross-sections (note the different magnifications/scaling bars). The white arrows show evidence of the progression of material removal and degradation site.CC BY · PubMed Central
Figure 7 (a) Percentage alamar blue reduction for cells only (MDA-MB-231 cells), drug-loaded and control PLGA-PEG microspheres after 6, 24, 48, 72 and 96 h post-treatment. (b) Percentage cell growth inhibition for drug-loaded and control PLGA-PEG microspheres after 6, 24, 48, 72 and 96 h’ post-treatment [*p < 0.05 (n = 4)].
Figure 7 (a) Percentage alamar blue reduction for cells only (MDA-MB-231 cells), drug-loaded and control PLGA-PEG microspheres after 6, 24, 48, 72 and 96 h post-treatment. (b) Percentage cell growth inhibition for drug-loaded and control PLGA-PEG microspheres after 6, 24, 48, 72 and 96 h’ post-treatment [*p < 0.05 (n = 4)].CC BY · PubMed Central
Figure 8 (a) Cell viability study of MDA-MB-231 cells showing the effect of the treatment time when incubated with drug-loaded and unloaded PLGA-PEG microspheres after for a period of 240 h with MDA-MB-231 cells acting as a control. (b) Representative confocal images of MDA-MB-231 cells after 5 h incubation with respective drug-loaded PLGA-PEG microspheres at 37 °C. Red staining reveals actin-filaments and green staining indicates vinculin. All cells were stained and imaged under the same conditions. White arrows indicate the initiation of cytoskeleton disruption/disintegration (n = 3, $p < 0.05 vs. control).
Figure 8 (a) Cell viability study of MDA-MB-231 cells showing the effect of the treatment time when incubated with drug-loaded and unloaded PLGA-PEG microspheres after for a period of 240 h with MDA-MB-231 cells acting as a control. (b) Representative confocal images of MDA-MB-231 cells after 5 h incubation with respective drug-loaded PLGA-PEG microspheres at 37 °C. Red staining reveals actin-filaments and green staining indicates vinculin. All cells were stained and imaged under the same conditions. White arrows indicate the initiation of cytoskeleton disruption/disintegration (n = 3, $p < 0.05 vs. control).CC BY · PubMed Central
Figure 9 (a) Body weight variation of subcutaneous xenograft tumor-bearing mice treated with drug-loaded microparticles in the presence of control (n = 5, ^p < 0.05) (b) Kaplan Meier survival curves (N = 30) showing the effect of all treatment groups on the survival rate of mice.
Figure 9 (a) Body weight variation of subcutaneous xenograft tumor-bearing mice treated with drug-loaded microparticles in the presence of control (n = 5, ^p < 0.05) (b) Kaplan Meier survival curves (N = 30) showing the effect of all treatment groups on the survival rate of mice.CC BY · PubMed Central
Figure 10 (I) Representative photographs showing the steps involved in the treatment of the TNBC tumor with drug-loaded microspheres: (a) subcutaneous xenograft TNBC tumor; (b) surgical tumor removal; (c) residual tumor; (d) stitched residual tumor with implanted drug-loaded microspheres; (e) healing scar 8 weeks after surgery and (f) completely healed mice 18 weeks after surgery and treatment with targeted drug-loaded microspheres (PLGA-PEG_PGSLHRH). (II) (a–c) Representative mice treated with non-drug microparticles (PLGA-PEG) with recurred tumor.
Figure 10 (I) Representative photographs showing the steps involved in the treatment of the TNBC tumor with drug-loaded microspheres: (a) subcutaneous xenograft TNBC tumor; (b) surgical tumor removal; (c) residual tumor; (d) stitched residual tumor with implanted drug-loaded microspheres; (e) healing scar 8 weeks after surgery and (f) completely healed mice 18 weeks after surgery and treatment with targeted drug-loaded microspheres (PLGA-PEG_PGSLHRH). (II) (a–c) Representative mice treated with non-drug microparticles (PLGA-PEG) with recurred tumor.CC BY · PubMed Central
Figure 11 (I) Representative immunofluorescence images of LHRH receptors (green stain) expressed on the (a) tumor, and (b) lungs of mice treated with a control microspheres (PLGA-PEG) and their corresponding H&E stain showing metastasis in the (c) tumor and (d) lungs. (II) Optical images of mice lungs treated with (a) PLGA-PEG_PTX, (b) PLGA-PEG_PGS, (c) PLGA-PEG_PTX-LHRH, (d) PLGA-PEG_PGS-LHRH microspheres.
Figure 11 (I) Representative immunofluorescence images of LHRH receptors (green stain) expressed on the (a) tumor, and (b) lungs of mice treated with a control microspheres (PLGA-PEG) and their corresponding H&E stain showing metastasis in the (c) tumor and (d) lungs. (II) Optical images of mice lungs treated with (a) PLGA-PEG_PTX, (b) PLGA-PEG_PGS, (c) PLGA-PEG_PTX-LHRH, (d) PLGA-PEG_PGS-LHRH microspheres.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 91 references

Research works printed but not linked: 4

  1. Patil, P. B., Uphade, K. B. & Saudagar, R. B. A review: Osmotic drug delivery system. Pharma Sci. Monit. 9, 2 (2018).
  2. Zhang, Z. G., Sun, A. P. & Long, L. X. Effect of physicochemical properties of drugs on morphology and release of microspheres. J. Med. Biol. Eng. https://doi.org/10.5405/jmbe.1070 (2014). · doi:10.5405/jmbe.1070
  3. Yang, R. et al. Cationic formulation of paclitaxel-loaded poly D, L-lactic-co-glycolic acid (PLGA) nanoparticles using an emulsion-solvent diffusion method. Asian J. Pharm. Sci. 4, 89 (2009).
  4. Narasimhan, B., Mallapragada, S. K. & Peppas, N. A. Release kinetics, data interpretation. Encycl. Control. Drug Deliv. 2, 921–935 (1999).

Cited by

See all 126

Metadata

Authors
Jusu, S. M., Obayemi, J. D., Salifu, A. A., Nwazojie, C. C., Uzonwanne, V., Odusanya, O. S., & Soboyejo, W. O.
Affiliations
  • Worcester Polytechnic Institute (US)
  • African Institute of Science and Technology (NG)
Corresponding author
Soboyejo, W. O.
Venue
Scientific Reports
Published
2020-08-25
Volume
10
Issue
1
Pages
14188-14188
ISSN
2045-2322 (ISSN-L)
OpenAlex
W3080177289
Cited by
112
References
91
Citations by year
2026: 9 · 2025: 19 · 2024: 23 · 2023: 18 · 2022: 28 · 2021: 15
FWCI
3.97
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
African Center of Excellence (ACE) Program through the Pan-African Materials Institute (P126974)
Topics
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
  • Physical Sciences › Engineering › Biomedical Engineering › Ultrasound and Hyperthermia Applications
Keywords
triple-negative breast cancer, targeted drug delivery, prodigiosin, paclitaxel, sustained drug release, Korsmeyer-Peppas model, tumor recurrence prevention
MeSH terms
Animals, Antineoplastic Agents, Phytogenic, Calorimetry, Differential Scanning, Delayed-Action Preparations, Drug Carriers, Female, Humans, Gonadotropin-Releasing Hormone, Ligands, Lung Neoplasms, Mice, Nude, Microscopy, Electron, Scanning, Microspheres, Neoplasm Proteins, Polyesters, Polyethylene Glycols, Receptors, LHRH, Thermodynamics, Thermogravimetry, Drug Delivery Systems, Paclitaxel, Spectroscopy, Fourier Transform Infrared, Xenograft Model Antitumor Assays, Cell Line, Tumor, Mice, Triple Negative Breast Neoplasms, Drug Liberation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Drug-encapsulated blend of PLGA-PEG microspheres: in vitro and in vivo study of the effects of localized/targeted drug delivery on the treatment of triple-negative breast cancer. https://app.cochat.ai/papers/10.1038/s41598-020-71129-0
The paper
Jusu, S. M., Obayemi, J. D., Salifu, A. A., Nwazojie, C. C., Uzonwanne, V., Odusanya, O. S., & Soboyejo, W. O. (2020). Drug-encapsulated blend of PLGA-PEG microspheres: in vitro and in vivo study of the effects of localized/targeted drug delivery on the treatment of triple-negative breast cancer. Scientific Reports. https://doi.org/10.1038/s41598-020-71129-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.